Log In
BCIQ
Print this Print this
 

ultrasound-activated liposomal formulation of doxorubicin

  Manage Alerts
Collapse Summary General Information
Company Epitarget A/S
DescriptionUltrasound-activated liposomal formulation of doxorubicin
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationProstate cancer
Indication DetailsTreat prostate cancer
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today